These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11466370)

  • 1. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition.
    Zahedi R; MacFarlane RC; Wisnieski JJ; Davis AE
    J Immunol; 2001 Aug; 167(3):1500-6. PubMed ID: 11466370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
    Zahedi R; Wisnieski J; Davis AE
    J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.
    Zahedi R; Bissler JJ; Davis AE; Andreadis C; Wisnieski JJ
    J Clin Invest; 1995 Mar; 95(3):1299-305. PubMed ID: 7883978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.
    Sulikowski T; Bauer BA; Patston PA
    Protein Sci; 2002 Sep; 11(9):2230-6. PubMed ID: 12192078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
    Davis AE; Aulak K; Parad RB; Stecklein HP; Eldering E; Hack CE; Kramer J; Strunk RC; Bissler J; Rosen FS
    Nat Genet; 1992 Aug; 1(5):354-8. PubMed ID: 1363816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
    Eldering E; Huijbregts CC; Nuijens JH; Hack CE
    Behring Inst Mitt; 1993 Dec; (93):125-30. PubMed ID: 8172559
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional analysis of the serpin domain of C1 inhibitor.
    Coutinho M; Aulak KS; Davis AE
    J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.
    Bally I; Rossi V; Lunardi T; Thielens NM; Gaboriaud C; Arlaud GJ
    J Biol Chem; 2009 Jul; 284(29):19340-8. PubMed ID: 19473974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of functional human C1 inhibitor in COS cells.
    Eldering E; Nuijens JH; Hack CE
    J Biol Chem; 1988 Aug; 263(24):11776-9. PubMed ID: 2841334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251.
    Zahedi R; Aulak KS; Eldering E; Davis AE
    J Biol Chem; 1996 Sep; 271(39):24307-12. PubMed ID: 8798678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant C1 inhibitor P1 variants.
    Eldering E; Huijbregts CC; Lubbers YT; Longstaff C; Hack CE
    J Biol Chem; 1992 Apr; 267(10):7013-20. PubMed ID: 1551909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 18. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
    Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
    J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitor.
    Bos IG; Lubbers YT; Eldering E; Abrahams JP; Hack CE
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):139-44. PubMed ID: 15158721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.